Use of erythrocytes sensitized with purified pneumococcal polysaccharides for the assay of antibody and antibody-producing cells.
about
Influence of multiple genes on the magnitude of the antibody response to bacterial polysaccharide antigensInfluence of carrier-specific, thymus-derived cells on the immunologlobulin M antibody response to staphylococcal lipoteichoic acid.Effect of gold on the immune response of mice.Heteroimmunization to the capsular polysaccharide of Haemophilus influenzae type b induced by enteric cross-reacting bacteria.Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide.Biological properties of an immunogenic pneumococcal subcellular preparation.Immunogenic cross-reactivity between human tissues and the enterobacterial common antigen.Autoantibodies detected in rabbits hyperimmunized with group A, C, and G streptococcal vaccines.Immune response to Cryptococcus neoformans soluble polysaccharide: immunological unresponsivenessPhytohemagglutinin stimulation of enhanced immunoglobulin G production in mice inoculated with type III pneumococcal polysaccharide.Immune response to Cryptococcus neoformans soluble polysaccharide. I. Serological assay for antigen and antibodyCorrelation of circulating capsular polysaccharide with bacteremia in pneumococcal pneumonia.A soluble suppressor T cell factor protects against experimental intraabdominal abscesses.T-cell modulation of the antibody response to bacterial polysaccharide antigens.Adjuvant effects of trehalose dimycolate on the antibody response to type III pneumococcal polysaccharideImmunomodulatory activity of monophosphoryl lipid A in C3H/HeJ and C3H/HeSnJ miceInactivation of suppressor T cell activity by the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides.Specific immunological unresponsiveness to bacterial lipopolysaccharides develops in a cyclic manner.Molecular structures that influence the immunomodulatory properties of the lipid A and inner core region oligosaccharides of bacterial lipopolysaccharidesStudies on the regulation of avidity at the level of the single antibody-forming cell. The effect of antigen dose and time after immunization.Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. I. Evidence that an X-linked gene plays a decisive role in determining responsiveness.Regulation of the antibody response to type 3 pneumococcal polysaccharide. I. Nature of regulatory cellsInability of mice with a defect in B-lymphocyte maturation to respond to phosphorycholine on immunogenic carriers.Host-parasite relationship in murine leishmaniasis: pathophysiological and immunological changesRole of a nonimmunoglobulin cell surface determinant in the activation of B lymphocytes by thymus-independent antigensSynthesis of two classes of antibody, gammaM and gammaG or gammaM and gammaA, by identical cells. Amplification of the antibody response to pneumococcal polysaccharide type III.Anti-idiotype induced regulation of helper cell function for the response to phosphorylcholine in adult BALB/c mice.The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B StreptococcusCharacterization of the murine immune response to type 6 pneumococcal polysaccharide.Neonatal treatment with low doses of anti-idiotypic antibody leads to the expression of a silent cloneImmunogenic properties in mice of hexasaccharide from the capsular polysaccharide of Streptococcus pneumoniae type 3.Activation of antigen-specific suppressor T cells by B cells from mice immunized with type III pneumococcal polysaccharide.Regulation of the antibody response to type III pneumococcal polysaccharide by contrasuppressor T cells.Antibody responses to a combination vaccine against Haemophilus influenzae type b, diphtheria, pertussis, and tetanus.Studies in chronic lymphocytic leukaemia II. Lymphocyte markers, cellular and humoral immunity and the effect of treatment.Immune responses of systemic and mucosal lymphoid organs to Pnu-Imune vaccine as a function of age and the efficacy of monophosphoryl lipid A as an adjuvant.Structural features that influence the ability of lipid A and its analogs to abolish expression of suppressor T cell activity.The glucuronoxylomannan of Cryptococcus neoformans serotype A is a type 2 T-cell-independent antigenAntigen-specific suppressor T cells respond to recombinant interleukin-2 and other lymphokines.Differential effects of monophosphoryl lipid A on expression of suppressor T cell activity in lipopolysaccharide-responsive and lipopolysaccharide-defective strains of C3H mice.
P2860
Q27487843-D945D4C4-41DC-4119-B90F-30E3678104D8Q33904971-50AADEE6-29BA-4C51-BB6A-28FBFF663722Q34115090-A7E58890-DC3F-483E-83FC-813AA6D43ABEQ34120272-51AFCA2A-20F2-4CD3-8981-4BF9CC8B82F7Q34166527-42599E3C-A9A5-4756-917C-B5EE89A439D7Q34389793-4A51C1AB-4F85-4465-BBA1-267CBB1A9544Q34411182-2B3D6855-22D8-4CB1-8DE1-24C8376AD5C8Q34420009-C578DF3D-4BF0-4DF5-AC44-158C50456CB2Q34420549-15262745-55C5-4A45-B391-63E862D7A217Q34463438-503AA5C1-D5C8-4AC5-B439-F84B55AC62EEQ34466900-261CBDE8-67DE-4299-8C3E-A9F225A19F71Q34477830-A95F2763-8A78-4546-9E7A-2189FD364460Q34537875-F15949D0-EA7F-4D1B-8808-A1480CE10949Q35089137-CE174447-3F45-4446-95FC-DCDC0290C03DQ35092791-8F5F8A46-2C12-45A8-9A27-8385F66C61E6Q35095801-F02E4693-EE3C-44A4-B063-E5695C6081AAQ35103731-4A008421-1871-4844-849F-301CE08C2EF8Q35112245-83554750-C7CE-4D2C-B121-2325F0403037Q35781825-7316501A-81F9-49FC-8146-1D0CA8F683D5Q36270069-66A0A700-48A5-49B9-AD73-E55139F4A5CAQ36271994-BA23A97F-8E00-4A4C-B7E0-963EE5CB1B95Q36272256-5CD82ACB-DBB2-4CAB-993A-D41CB7D8D961Q36335955-A2E173C5-1CFA-449A-A720-99EA522CD6DCQ36340518-F4631E07-0AEE-43BC-9C77-A30461611E89Q36341241-6CCC1384-646E-462F-86C9-C60DE2B7508BQ36341436-F52B5B54-F31B-40F4-8118-ECA7D88CC654Q36342037-5304D101-65C3-49AF-9730-2D6FB814C3E4Q36343590-D60A648E-A8DE-4F4F-A3A3-856323DE673EQ36344081-09B1CD12-BEED-497E-8904-EF0242863BE5Q36344651-0CEDD791-1F1D-460E-B9C5-D676DF62BC5CQ36347721-F83E9EB3-BDDF-4CE9-A522-F2F6E8487760Q36348113-0F06EFDF-ABD9-45E6-9D3C-983BD0233C62Q36349258-0F578A6C-984B-4A3E-8A1B-D49EE1FBCC28Q36629739-F0C11215-8BB5-4043-B37B-41D1E2BABA9BQ36715660-99CA2DA3-3C58-49BE-B17A-B9995581ADB9Q36946071-37C47EC5-E6F1-45F1-B572-6B0105CDF87BQ36947204-942E9BD9-F5C3-4DF1-92AE-0F3D5CCE8AFAQ36951576-E67B538A-A5AF-4409-A235-180A80BB85B6Q36961404-278BE797-BA39-4102-A493-79A7F1283C51Q36965544-E39EFE27-CFDD-4E7D-B069-3CB1F3BD14DE
P2860
Use of erythrocytes sensitized with purified pneumococcal polysaccharides for the assay of antibody and antibody-producing cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1969
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Use of erythrocytes sensitized ...... and antibody-producing cells.
@en
Use of erythrocytes sensitized ...... and antibody-producing cells.
@nl
type
label
Use of erythrocytes sensitized ...... and antibody-producing cells.
@en
Use of erythrocytes sensitized ...... and antibody-producing cells.
@nl
prefLabel
Use of erythrocytes sensitized ...... and antibody-producing cells.
@en
Use of erythrocytes sensitized ...... and antibody-producing cells.
@nl
P2093
P2860
P1433
P1476
Use of erythrocytes sensitized ...... and antibody-producing cells.
@en
P2093
P2860
P304
P577
1969-03-01T00:00:00Z